Delaware Street Drug Report
August 2026 | Report #2026-14
Approved: August 17, 2026
Contact: ORC@delaware.gov
Disclaimer
This report is for risk mitigation and educational purposes only and should not be used for professional or publication use. The data included is from sporadic drug residue testing across various locations in Delaware and should not be over generalized. Stamp names are not universal or consistent in the street supply and are provided here for reference only.
The selected stamps below are from samples collected during July 2026.
Select Stamps and Compounds Detected
Bad ASS
Caffeine, Fentanyl, Phenacetin, Procaine
BugyBoo
Acetaminophen, Fentanyl, Fluorofentanyl, Quinine
Coleslaw
Acetaminophen, Fentanyl, Fluorofentanyl, Quinine
Coleslaw
Acetaminophen, Cocaine, Fentanyl, Fluorofentanyl, Quinine
CoolCat
Acetaminophen, Fentanyl, Fluorofentanyl, Quinine
German
Cocaine
Honda
4-ANPP, Fentanyl, Lidocaine, Medetomidine, Tetracaine
Pepsi
Fentanyl, Medetomidine
The Joker
4-ANPP, Fentanyl, Medetomidine, Procaine, Tetracaine
White House
Fentanyl, Medetomidine, Tetracaine
White House
Benzoylecgonine, Cocaine
Used Device
Cocaine, Phenacetin
Used Device
Cocaine, Fentanyl, Phenacetin
Used Device
Benzoylecgonine, Cannabinol, Cocaine, Medetomidine, Phenacetin, THC
Substance Highlights
Phenacetin
Phenacetin is commonly used as an adulterant in cocaine and more recently opioid supplies. It is a known carcinogen (proven cause of cancer), is toxic to the kidneys, and can damage the heart, blood, and urinary system.
Fluorofentanyl
A synthetic opioid that is a structural analog of fentanyl. It is similar to fentanyl, but may be slightly less potent. It is most commonly detected with fentanyl, cocaine, or methamphetamine.
Cocaine
An intense, DEA Schedule II stimulant with strong addictive potential that causes restlessness, paranoia, insomnia, loss of appetite, irregular heartbeat, and seizures.
Trending Substances
| Compound Detected | Feb. 2026 | Mar. 2026 | Apr. 2026 | May 2026 | Jun. 2026 | Jul. 2026 |
|---|---|---|---|---|---|---|
| Samples Tested | 25 | 17 | 42 | 64 | 137 | 72 |
| Xylazine | 8% | 35% | 2% | 5% | 1% | 0% |
| Medetomidine | 88% | 65% | 21% | 36% | 24% | 15% |
| Fentanyl | 96% | 77% | 71% | 42% | 23% | 19% |
| Tetracaine | 84% | 24% | 43% | 27% | 20% | 11% |
| Procaine | 84% | 24% | 45% | 11% | 7% | 3% |
| Lidocaine | 20% | 6% | 2% | 9% | 4% | 1% |
| 4-ANPP | 52% | 41% | 29% | 11% | 8% | 4% |
| BTMPS | 4% | 0% | 0% | 0% | 0% | 1% |
| Fluorofentanyl | 0% | 0% | 0% | 0% | 0% | 6% |
| Cocaine | 8% | 29% | 37% | 56% | 70% | 78% |
| Methamphetamine | 8% | 18% | 7% | 6% | 3% | 1% |
| Pregabalin | 0% | 0% | 0% | 0% | 0% | 0% |
| Heroin | 4% | 0% | 2% | 0% | 1% | 0% |
| Carfentanil | 0% | 0% | 0% | 0% | 0% | 0% |
| Quinine | 4% | 0% | 2% | 0% | 1% | 6% |
| Levamisole | 0% | 6% | 2% | 2% | 0% | 0% |
July 2026 Trends
This month had the first detection of fluorofentanyl so far this year and also marked the first time that xylazine was not detected in any samples.
Continuing the trend from previous months, the prevalence of cocaine reached 78% of samples tested, the highest prevalence rate so far.
It is important to remember that this testing is a convenience sample, meaning the vast majority of samples are volunteered by individuals to be tested and is not random or even sampling of the general Delaware drug supply. This change in prevalence is mostly driven from users of stimulants increasingly submitting samples for testing.